DOI: 10.1148/rg.251045074
RadioGraphics 2005;25:69-85
© RSNA, 2005
CT and MR Imaging of Extrahepatic Fatty Masses of the Abdomen and Pelvis: Techniques, Diagnosis, Differential Diagnosis, and Pitfalls1
Jose M. Pereira, MD,
Claude B. Sirlin, MD,
Pedro S. Pinto, MD and
Giovanna Casola, MD
1 From the Department of Radiology, Porto Medical School, Hospital S. João, Porto, Portugal (J.M.P., P.S.P.); and the Department of Radiology, University of California Medical Center, 200 W Arbor Dr, San Diego, CA 92103-8756 (C.B.S., G.C.). Presented as an education exhibit at the 2003 RSNA Scientific Assembly. Received April 14, 2004; revision requested May 18 and received June 29; accepted June 30. All authors have no financial relationships to disclose. Address correspondence to C.B.S. (e-mail: csirlin@ucsd.edu).
 |
Abstract
|
|---|
The differential diagnosis of extrahepatic abdominopelvic masses is wide. Demonstration of fat within a lesion at noninvasive imaging is an important clue for narrowing the differential diagnosis. Macroscopic fat is readily identified with both computed tomography (CT) and magnetic resonance (MR) imaging. Demonstration of microscopic fat is more difficult and may require special techniques. Identification of fat with CT is based on x-ray resorption and therefore on the attenuation (typically less than –20 HU). Several MR imaging techniques have been developed for fat suppression. Two of the most widely available are spectroscopic fat saturation and chemical shift (in-phase/opposed-phase) imaging. Entities with predominantly macroscopic fat include myelolipoma, angiomyolipoma, teratoma, liposarcoma, lipoma, epiploic appendagitis, omental infarction, and mesenteric panniculitis. Lesions with predominantly microscopic fat include adrenal adenoma and some teratomas. Other fat-containing entities involve the mesentery and bowel wall; these include fibrofatty mesenteric proliferation and submucosal fat deposition.
© RSNA, 2005
|
LEARNING OBJECTIVES
|
|---|
After reading this article and taking the test, the reader will be able to:
- Discuss how to identify intralesion fat with CT and different MR imaging techniques.
- List the major differential diagnoses for the presence of fat in an extrahepatic abdominopelvic lesion.
- Describe the main clinical and radiologic features of fat-containing lesions in the abdomen and pelvis.
|
Introduction
|
|---|
Extrahepatic fat-containing masses of the abdomen and pelvis represent a broad spectrum of congenital, metabolic, inflammatory, traumatic, degenerative, and neoplastic processes. They can be divided into fat-containing neoplasms, fat-containing nonneoplastic masses, and other abdominopelvic fatty masses. Lesions with predominantly macroscopic fat include myelolipoma, angiomyolipoma, lipoma, liposarcoma, teratoma, epiploic appendagitis, fat infarction, and mesenteric panniculitis. Lesions with predominantly microscopic fat include adrenal adenoma and some teratomas. Other less common fatty masses include diaphragmatic and abdominal wall hernias, intussusception, fibrofatty mesenteric proliferation, and submucosal fat deposition.
Knowledge of clinical, anatomic, and imaging features is important in formulating an appropriate differential diagnosis and guiding patient care. The location of the fat-containing lesion is a critical parameter in formulating the correct diagnosis. Definitive noninvasive diagnosis of fatty lesions is usually possible with computed tomography (CT) or magnetic resonance (MR) imaging. Ultrasound (US) findings may be suggestive but are rarely diagnostic, and CT or MR imaging confirmation is usually necessary. Consequently, this review emphasizes CT and MR imaging. Correlative US findings are shown in select cases.
|
How to Identify Intralesion Fat
|
|---|
Computed Tomography
Identification of fat at computed x-ray tomography (CT) is based on x-ray resorption and therefore attenuation. Fat has lower attenuation than water. Hence, if the proportion of fat within a voxel is large, the corresponding image pixel will be dark, typically measuring less than –20 HU (Fig 1) (1). Identification of macroscopic fat is usually simple, although high spatial resolution may be required to depict minute quantities. Microscopic fat may be difficult to identify reliably, as mixing of higher-attenuation water and protein increases the mean CT number. For this reason, CT is not as sensitive for detecting microscopic fat as MR imaging (2).
MR Imaging
Fat has short T1 and relatively long T2 relaxation and thus appears hyperintense on T1-weighted and intermediately intense to hyperintense on T2-weighted fast spin-echo and gradient-echo images. However, these signal intensities are nonspecific, and signal intensity on T1- and T2-weighted images does not allow reliable identification of fat. To reliably identify fat, it is necessary to exploit the different resonance frequencies of water and fat protons.
Chemical shift artifacts are caused by spatial mismapping of fatty and water-based tissue along the frequency-encoding axis. The shift in pixels is equal to the chemical shift (in hertz) between fat and water protons (approximately 220 Hz at 1.5 T and 440 Hz at 3 T) divided by the bandwidth (in hertz per pixel). Thus, this artifact is more pronounced at high field strength or with low bandwidth pulse sequences. This kind of chemical shift artifact occurs when spin-echo and gradient-echo sequences are used (3).
Chemical shift also explains in-phase/opposed-phase imaging. Water and fat signal may be in phase (signal is additive) or opposed phase (signal is canceled), depending on the echo time (3). Typically, at 1.5 T, fat and water signal are maximally out of phase when an echo time of 2.2–2.3 msec is used (or 6.6–6.9 msec, 11.0–11.5 msec, etc) and maximally in phase when an echo time of 4.4–4.6 msec is used (or 8.8–9.2 msec, 13.2–13.8 msec, etc) (Fig 2).
View larger version (157K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2a. Mature cystic teratoma of the ovary in a 27-year-old woman. (a) Axial in-phase gradient-echo MR image (repetition time msec/echo time msec = 120/4.4) shows a heterogeneous predominantly hyperintense mass in the right ovary (arrow). The hyperintense component is consistent with fat or hemorrhage. (b) Axial out-of-phase gradient-echo MR image (120/2.2) shows partial signal loss in the central nodule. More important, there is dramatic signal loss at the interface between the lesion and the water-based ovarian tissue stretched around it (arrowheads). This finding indicates that the lesion contains fat. (c) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal loss (arrow) relative to the signal intensity on the in-phase image (a), an appearance indicative of a predominantly macroscopic fatty component.
|
|
View larger version (163K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2b. Mature cystic teratoma of the ovary in a 27-year-old woman. (a) Axial in-phase gradient-echo MR image (repetition time msec/echo time msec = 120/4.4) shows a heterogeneous predominantly hyperintense mass in the right ovary (arrow). The hyperintense component is consistent with fat or hemorrhage. (b) Axial out-of-phase gradient-echo MR image (120/2.2) shows partial signal loss in the central nodule. More important, there is dramatic signal loss at the interface between the lesion and the water-based ovarian tissue stretched around it (arrowheads). This finding indicates that the lesion contains fat. (c) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal loss (arrow) relative to the signal intensity on the in-phase image (a), an appearance indicative of a predominantly macroscopic fatty component.
|
|
View larger version (142K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2c. Mature cystic teratoma of the ovary in a 27-year-old woman. (a) Axial in-phase gradient-echo MR image (repetition time msec/echo time msec = 120/4.4) shows a heterogeneous predominantly hyperintense mass in the right ovary (arrow). The hyperintense component is consistent with fat or hemorrhage. (b) Axial out-of-phase gradient-echo MR image (120/2.2) shows partial signal loss in the central nodule. More important, there is dramatic signal loss at the interface between the lesion and the water-based ovarian tissue stretched around it (arrowheads). This finding indicates that the lesion contains fat. (c) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal loss (arrow) relative to the signal intensity on the in-phase image (a), an appearance indicative of a predominantly macroscopic fatty component.
|
|
Frequency-selective fat suppression techniques reduce the signal from lipid-containing voxels by applying a preparatory pulse with an appropriate frequency to saturate fat protons (4). This technique effectively reduces macroscopic fat signal, such as in lipomas and most teratomas. Frequency-selective fat suppression requires a homogeneous external magnetic field. In regions of magnetic heterogeneity, such as at air–soft tissue interfaces, frequency-selective fat suppression frequently fails.
Chemical shift (in-phase/opposed-phase) imaging is more sensitive to microscopic quantities of fat than frequency-selective fat suppression (or attenuation-based CT methods). The reason is that opposed-phase imaging causes signal from fat and water to cancel out. Frequency-selective fat suppression simply eliminates signal from fat, so a larger amount of fat is required for its effect to be noticeable (5).
An advantage of frequency-selective fat suppression is that it is available for both spin-echo and gradient-echo pulse sequences. In-phase/opposed-phase chemical shift imaging generally is possible only with gradient-echo imaging because the 180o refocusing pulse(s) of spin-echo and fast spin-echo sequences bring fat and water protons back into phase and eliminate the phase differences.
Signal intensity from fat can also be suppressed with short inversion time inversion-recovery (STIR) techniques (6). However, as signal suppression in this technique depends on T1 properties of tissues, other tissue components with a T1 similar to that of fat (subacute hemorrhagic products) also lose signal. Therefore, STIR should not be used to characterize fat. STIR should also not be used after administration of a paramagnetic contrast agent such as a gadolinium chelate, because the T1 of tissues accumulating the agent may become similar to the T1 of fat, resulting in signal reduction of the target tissue and loss of contrast enhancement.
Other methods of identifying fat are water-selective spatial spectral techniques, Dixon techniques, and MR spectroscopy. These are not widely used in abdominopelvic applications now and are not discussed herein.
|
Fat-containing Neoplasms
|
|---|
Myelolipoma
Myelolipoma is an uncommon benign tumor composed of mature adipose cells and hematopoietic tissue. The prevalence in autopsy series is between 0.08% and 0.2% (7). Typically, myelolipoma arises in the adrenal gland. Extra-adrenal myelolipoma is rare and is found most commonly in the presacral and other retroperitoneal areas (8). Usually asymptomatic and discovered incidentally at cross-sectional imaging, myelolipoma occasionally causes discomfort due to compression or hemorrhage.
The CT features are characteristic. Lesions usually have a negative Hounsfield unit value owing to macroscopic fat (Fig 1). Because of intermixed hematopoietic tissue, the attenuation is usually higher than that of retroperitoneal fat (Figs 3, 4). High-attenuation regions may be seen due to hemorrhage or calcifications.
View larger version (179K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3. Adrenal myelolipoma. Axial CT image shows a well-defined mass with predominantly soft tissue attenuation in the left adrenal gland. Note the nodule of fat attenuation (arrow), which is characteristic of myelolipoma.
|
|
View larger version (165K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 4. Adrenal myelolipoma. Axial CT image enhanced with intravenous contrast material shows a heterogeneous left adrenal mass (arrows) with fatty and enhancing soft tissue components. The presence of fat permits reliable diagnosis of a benign myelolipoma despite the soft tissue elements.
|
|
At MR imaging, the fatty component is usually hyperintense on T1-weighted images and heterogeneously hyperintense on T2-weighted images due to nonuniform admixture of fat and marrow components. This appearance is nonspecific and may be mimicked by adrenal metastases or primary adrenal cancers. Frequency-selective fat suppression allows the diagnosis of myelolipoma to be confirmed by demonstrating signal loss (Fig 5). Fat-containing malignancies of the adrenal gland are exceedingly rare (9); thus, adrenal malignancies would not be expected to lose signal on fat-suppressed images. Chemical shift in-phase/opposed-phase imaging may also be diagnostic by demonstrating india ink or etching artifacts between fat- and water-based components. India ink or etching artifacts are produced at boundaries between fat- and water-based tissues. The reason is that the voxels along those boundaries contain both fat and water protons and hence lose signal on opposed-phase relative to in-phase images.
View larger version (136K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 5a. Adrenal myelolipoma. (a) Axial in-phase MR image shows a heterogeneous predominantly hyperintense lesion (arrows), which is a nonspecific appearance. (b) Axial out-of-phase MR image shows dramatic signal loss at the interface between water- and lipid-based components (arrows), thus permitting noninvasive diagnosis of the lesion. (c) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows diminished signal intensity in the macroscopic fatty component (arrowhead), a finding that confirms the diagnosis.
|
|
View larger version (132K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 5b. Adrenal myelolipoma. (a) Axial in-phase MR image shows a heterogeneous predominantly hyperintense lesion (arrows), which is a nonspecific appearance. (b) Axial out-of-phase MR image shows dramatic signal loss at the interface between water- and lipid-based components (arrows), thus permitting noninvasive diagnosis of the lesion. (c) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows diminished signal intensity in the macroscopic fatty component (arrowhead), a finding that confirms the diagnosis.
|
|
View larger version (134K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 5c. Adrenal myelolipoma. (a) Axial in-phase MR image shows a heterogeneous predominantly hyperintense lesion (arrows), which is a nonspecific appearance. (b) Axial out-of-phase MR image shows dramatic signal loss at the interface between water- and lipid-based components (arrows), thus permitting noninvasive diagnosis of the lesion. (c) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows diminished signal intensity in the macroscopic fatty component (arrowhead), a finding that confirms the diagnosis.
|
|
Adenoma
Adrenal adenoma is a common tumor, with a prevalence of 3% in autopsy series (10). As the majority of lesions are small and nonfunctional, most adenomas are incidental findings ("adrenal incidentalomas"). Hyperfunctional adenomas also occur and are responsible for important endocrine disorders such as Cushing syndrome and Conn syndrome.
At pathologic analysis, both hyperfunctioning and nonfunctional adenomas contain a variable amount of intracytoplasmic fat. Lipid-rich adenomas (approximately 80% of adenomas) are easily identified at both CT and MR imaging. At CT, adrenal adenomas appear as small (<3 cm), well-defined homogeneous masses that are typically hypoattenuating relative to the liver (Fig 6). Lee et al (9) demonstrated that an attenuation value of less than 0 HU at unenhanced CT is diagnostic of an adenoma with 100% confidence; however, this threshold has only 47% sensitivity. In a series by Korobkin et al (11), a cutoff of 18 HU permitted a diagnosis of adenoma with 100% specificity and 85% sensitivity, compared to the specificity:sensitivity ratio of 68%:100% with a more conservative cutoff of 10 HU. A rational approach advocated by some authorities is to choose the CT number threshold on the basis of the patient’s risk for metastatic disease. For example, a threshold of 10 HU could be applied to older patients or to those with known primary malignancies. A threshold of 18 HU could be applied to younger patients without underlying cancer.
View larger version (183K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 6a. Adrenal adenoma. Axial unenhanced (a) and contrast material-enhanced (b) CT images show a low-attenuation mass in the left adrenal gland (arrow). The mass has an attenuation value of 3 HU on the unenhanced image (a) and 9 HU on the contrast-enhanced image (b). This result suggests the presence of microscopic fat, a finding compatible with adenoma.
|
|
View larger version (186K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 6b. Adrenal adenoma. Axial unenhanced (a) and contrast material-enhanced (b) CT images show a low-attenuation mass in the left adrenal gland (arrow). The mass has an attenuation value of 3 HU on the unenhanced image (a) and 9 HU on the contrast-enhanced image (b). This result suggests the presence of microscopic fat, a finding compatible with adenoma.
|
|
Lipid-poor adenomas are more difficult to diagnose because the CT numbers increase and approach those of soft tissue. Contrast-enhanced imaging with 10-minute-delayed CT scans may be helpful in these cases. By using a threshold of 30 HU, the sensitivity and specificity for delayed contrast-enhanced CT in the characterization of benign disease are 80% and 100%, respectively. A relative percentage washout of more than 50% in the delayed study represents a sensitivity and specificity of 98% and 100%, respectively, for the detection of adenoma (12).
Chemical shift MR imaging is a reasonable second imaging test for further characterization when CT results are indeterminate (13). Because of the high sensitivity of chemical shift MR imaging to minute amounts of intravoxel fat, MR imaging demonstrates signal intensity loss on opposed-phase images in the majority of adenomas, with a sensitivity of 89% for lesions with an attenuation of 10–30 HU and 100% for lesions with an attenuation of 10–20 HU with a maintained specificity of 100% (Fig 7) (14). In a recent study (15), dynamic postgadolinium contrast-enhanced MR imaging was suggested to provide useful complementary information to the appearance of adrenal masses on in-phase and out-of-phase images. Twenty-five of 35 adrenal adenomas showed homogeneous capillary blush on immediate postgadolinium images, and 33 of 35 adrenal adenomas demonstrated rapid washout on 45-second postgadolinium images. Fat-suppressed images and STIR techniques have less sensitivity for detecting minute amounts of lipid and are of little if any benefit in lesion characterization.
View larger version (137K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 7a. Adrenal adenoma. Axial in-phase (a) and out-of-phase (b) chemical shift MR images show an adrenal nodule (arrow). There is homogeneous signal loss on the out-of-phase image (b) relative to the signal intensity on the in-phase image (a), a finding that confirms the presence of water- and lipid-based components.
|
|
View larger version (155K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 7b. Adrenal adenoma. Axial in-phase (a) and out-of-phase (b) chemical shift MR images show an adrenal nodule (arrow). There is homogeneous signal loss on the out-of-phase image (b) relative to the signal intensity on the in-phase image (a), a finding that confirms the presence of water- and lipid-based components.
|
|
However, neither CT densitometry nor chemical shift MR imaging is infallible in differentiating atypical adenoma, especially if large, from metastasis. Atypical adenomas may contain calcification, hemorrhage, or necrosis (16). In addition, adenomas may lack detectable amounts of intracytoplasmic lipid even at chemical shift MR imaging (17). In these cases, comparison to results of previous studies, short-term imaging follow-up, or biopsy may be necessary.
Angiomyolipoma
Angiomyolipoma, also called renal hamartoma, is a benign tumor composed of fat, smooth muscle, and thick-walled blood vessels. Individual cells have a mature, benign appearance, but the tissue architecture is abnormal. The fat component typically predominates. Although intratumoral blood vessels are thick-walled, hemorrhage is a frequent complication (18). Angiomyolipoma is the cause for bleeding in 16%–20% of patients with spontaneous perinephric hemorrhage (19). Necrosis and calcification are rare. The vast majority arise from the renal cortex. Typically, renal angiomyolipoma is discovered incidentally at cross-sectional imaging; the prevalence is 0.3%–3%. Extrarenal angiomyolipoma is rare and usually occurs in the liver (20).
There are two distinct epidemiologic forms. A sporadic form accounts for about 90% of cases and characteristically occurs in middle-aged women; the remaining cases are associated with tuberous sclerosis (21). The two forms are histologically indistinguishable but vary in their imaging features. In patients with tuberous sclerosis, angiomyolipomas tend to be multiple and bilateral, may be massive, and often are associated with multiple cysts; extrarenal manifestations of tuberous sclerosis are often seen, including lymphangioleiomyomatosis. Patients with the sporadic form often have small solitary tumors.
CT permits confident noninvasive diagnosis of renal angiomyolipoma. At CT, these lesions typically appear as well-defined, cortically based, predominantly fat-attenuation masses (Fig 8). However, intratumoral fat cannot be visualized at CT in approximately 4.5% of all angiomyolipomas; this can be explained by the predominance of blood vessels, muscle, or immature fat or the scattering of a small amount of fat within other components (22). The size at discovery is usually less than 5 cm. Heterogeneous soft tissue attenuation (due to hemorrhage or fibrosis or representing muscular and vascular components) may be evident (23). Contrast enhancement is variable and depends on the amount of soft tissue and vascularity (Fig 9).
View larger version (136K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 8a. Renal angiomyolipoma. (a) Longitudinal US image shows a hyperechoic lesion in the inferior pole of the left kidney (cursors). The differential diagnosis includes renal cell carcinoma and angiomyolipoma. (b) Axial CT image shows fat attenuation within the lesion (arrow), a finding indicative of an angiomyolipoma.
|
|
View larger version (153K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 8b. Renal angiomyolipoma. (a) Longitudinal US image shows a hyperechoic lesion in the inferior pole of the left kidney (cursors). The differential diagnosis includes renal cell carcinoma and angiomyolipoma. (b) Axial CT image shows fat attenuation within the lesion (arrow), a finding indicative of an angiomyolipoma.
|
|
View larger version (176K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 9a. Renal angiomyolipoma with a predominant soft tissue component and a tiny fatty component. Axial unenhanced (a), corticomedullary phase (b), nephrographic phase (c), and excretory phase (d) CT images show a heterogeneous mass in the lateral left kidney. The mass is predominantly of soft tissue attenuation and superficially resembles a renal cell carcinoma; however, the presence of focal areas of fat attenuation (CT number, –20 HU or lower) (arrows) permits confident diagnosis of an angiomyolipoma.
|
|
View larger version (184K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 9b. Renal angiomyolipoma with a predominant soft tissue component and a tiny fatty component. Axial unenhanced (a), corticomedullary phase (b), nephrographic phase (c), and excretory phase (d) CT images show a heterogeneous mass in the lateral left kidney. The mass is predominantly of soft tissue attenuation and superficially resembles a renal cell carcinoma; however, the presence of focal areas of fat attenuation (CT number, –20 HU or lower) (arrows) permits confident diagnosis of an angiomyolipoma.
|
|
View larger version (183K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 9c. Renal angiomyolipoma with a predominant soft tissue component and a tiny fatty component. Axial unenhanced (a), corticomedullary phase (b), nephrographic phase (c), and excretory phase (d) CT images show a heterogeneous mass in the lateral left kidney. The mass is predominantly of soft tissue attenuation and superficially resembles a renal cell carcinoma; however, the presence of focal areas of fat attenuation (CT number, –20 HU or lower) (arrows) permits confident diagnosis of an angiomyolipoma.
|
|
View larger version (182K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 9d. Renal angiomyolipoma with a predominant soft tissue component and a tiny fatty component. Axial unenhanced (a), corticomedullary phase (b), nephrographic phase (c), and excretory phase (d) CT images show a heterogeneous mass in the lateral left kidney. The mass is predominantly of soft tissue attenuation and superficially resembles a renal cell carcinoma; however, the presence of focal areas of fat attenuation (CT number, –20 HU or lower) (arrows) permits confident diagnosis of an angiomyolipoma.
|
|
MR imaging allows correct characterization of most angiomyolipomas because of intratumoral fat deposition. The intratumoral fat can be confidently identified by using fat suppression techniques or by demonstrating an india ink or etching artifact at the interface of the water-based kidney and the fat-containing tumor (Fig 10). However, if a lesion is small relative to the section thickness and the voxel size, signal loss may artifactually appear to be complete or nearly complete rather than peripheral (Fig 10b). The reason is that volume averaging may occur between the hyperintense center of a small lesion and its hypointense out-of-plane edge. Intuitively, the degree of central signal loss can be predicted by the size of the lesion, the section thickness, and the voxel size. MR imaging offers no definite diagnostic advantage over CT (24,25) but should be considered in younger patients because of the absence of ionizing radiation.
View larger version (112K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 10a. Angiomyolipoma. (a) Axial in-phase gradient-echo MR image (echo time = 4.4 msec) shows a hyperintense focus in the right kidney (arrow). The differential diagnosis includes a fatty lesion and a hemorrhagic cyst. (b) Axial out-of-phase gradient-echo MR image (echo time = 2.2 msec) shows signal loss at the interface of the fatty lesion and the water-based renal parenchyma (arrow). This finding indicates that the lesion is an angiomyolipoma and not a hemorrhagic cyst.
|
|
View larger version (125K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 10b. Angiomyolipoma. (a) Axial in-phase gradient-echo MR image (echo time = 4.4 msec) shows a hyperintense focus in the right kidney (arrow). The differential diagnosis includes a fatty lesion and a hemorrhagic cyst. (b) Axial out-of-phase gradient-echo MR image (echo time = 2.2 msec) shows signal loss at the interface of the fatty lesion and the water-based renal parenchyma (arrow). This finding indicates that the lesion is an angiomyolipoma and not a hemorrhagic cyst.
|
|
The most important differential diagnosis for large exophytic angiomyolipomas is retroperitoneal (perirenal) liposarcoma. Multiplanar acquisition (MR imaging) or reformation (CT) may be necessary to differentiate the renal-based angiomyolipoma from a retroperitoneal liposarcoma. A careful evaluation for a sharp defect in the renal parenchyma and the presence of enlarged vessels and associated angiomyolipomas should enable accurate differentiation of these lesions in almost all cases. Liposarcoma does not cause a defect in the renal parenchyma, and the interface of the lesion with the kidney is smooth (26). Angiomyolipomas commonly contain enlarged vessels that can be seen at contrast-enhanced CT. In comparison, well-differentiated liposarcomas are relatively avascular. There is a potential for CT and MR angiography in the evaluation of difficult cases by demonstrating the renal artery origin of the feeding arteries supplying most angiomyolipomas (26).
Bleeding occurs frequently in angiomyolipomas and may mask the fat component (Fig 11). In such cases, imaging features may suggest renal cell carcinoma (RCC) (27,28). Angiomyolipomas with minimal fat can mimic RCC, leading to unnecessary surgery. Biphasic helical CT may be useful in the differentiation of these two entities (22). Homogeneity of tumor enhancement and the prolonged enhancement pattern of angiomyolipomas with minimal fat, in contrast to the heterogeneous enhancement and early washout pattern seen in most cases of RCC, are the most valuable CT findings. Rarely, RCC may contain small amounts of fat, usually because the tumor has engulfed a portion of the renal sinus or perirenal fat. Although clear cell type RCC could conceivably have a similar appearance to angiomyolipoma, signal loss at opposed-phase imaging is extremely rare in RCC and differentiation is usually possible on the basis of other findings. RCC rather than angiomyolipoma should be suspected when one or more of the following findings are present: intratumoral calcification, invasion of perirenal or sinus fat, small foci of fat within a large necrotic tumor, and enlarged nonfatty lymph nodes or venous invasion (29).
View larger version (119K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 11a. Massive right renal angiomyolipoma with hemorrhage in a patient with tuberous sclerosis several years after left nephrectomy. (a) Axial unenhanced CT image shows a huge heterogeneous mass of predominantly fat attenuation replacing the right kidney (arrows). The kidney itself is virtually unrecognizable. (b) Axial CT image obtained inferior to a shows a nodular area of high attenuation (arrow), which is suggestive of hemorrhage. Note the surrounding hemorrhage on both images (arrowhead in a, arrowheads in b).
|
|
View larger version (146K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 11b. Massive right renal angiomyolipoma with hemorrhage in a patient with tuberous sclerosis several years after left nephrectomy. (a) Axial unenhanced CT image shows a huge heterogeneous mass of predominantly fat attenuation replacing the right kidney (arrows). The kidney itself is virtually unrecognizable. (b) Axial CT image obtained inferior to a shows a nodular area of high attenuation (arrow), which is suggestive of hemorrhage. Note the surrounding hemorrhage on both images (arrowhead in a, arrowheads in b).
|
|
Renal lipoma is an unusual benign tumor. CT and MR imaging findings do not differ from those of angiomyolipoma with a predominant fatty component. The diagnosis can be established only by means of histologic findings, which are rarely available because these cases do not require surgery.
Liposarcomas arising from the kidney are extremely rare. They generally are larger at presentation, tend to be invasive, and are treated surgically if possible (30).
Cortical defects, either congenital or from scarring, may simulate small angiomyolipomas, especially at US. Moreover, small renal cell carcinomas and angiomyolipomas can have an identical sonographic appearance. However, some sonographic features are typical of angiomyolipomas, including acoustic shadowing and a stronger echogenicity than the renal sinus (31,32), and when present may not warrant further imaging. When an echogenic mass is less typical, further imaging should be performed.
Teratoma
Ovarian teratomas are the most common germ cell neoplasms. By far, most ovarian teratomas are mature cystic teratomas (MCTs), also known as dermoid cysts.
MCTs are composed of well-differentiated derivations from at least two germ cell layers (ectoderm, mesoderm, or endoderm). Ectodermal tissue (skin derivates and neural tissue) is invariably present. Mesodermal tissue (fat, bone, cartilage, muscle) is present in over 90% of cases, and endodermal tissue (gastrointestinal and bronchial epithelium, thyroid tissue) is seen in the majority (33). MCTs are the most common benign ovarian tumors in women less than 45 years old. The tumors are bilateral in 10% of cases (33). Although most mature teratomas are asymptomatic, abdominal pain or other nonspecific symptoms occur in a minority of patients. Important complications of MCT are torsion, rupture, and malignant degeneration (34,35). Because of the slow growth of these tumors (average of 1.8 mm per year), some authors advocate nonsurgical management of smaller (<6 cm) lesions (36).
MCTs are unilocular in 88% of cases and filled with sebaceous material. A raised protuberance known as the Rokitansky nodule (dermoid plug) may project into the cystic cavity. Bone or teeth, if present, tend to be located within this nodule.
At CT, fat attenuation within a cystic adnexal mass, with or without calcification in the wall, is diagnostic (Fig 12). Fat is reported is 93% of cases, and teeth or other calcifications are reported in 56% (37). Typically, the calcifications of MCTs are smooth and well defined.
View larger version (195K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 12a. Mature cystic teratoma of the left ovary. (a) Sagittal transabdominal US image shows a large, heterogeneous, predominantly hyperechoic mass (arrows). (b) Axial contrast-enhanced CT image shows the retrouterine mass (arrows), which is predominantly of fat attenuation. (c, d) Axial in-phase (c) and out-of-phase (d) MR images show signal loss at the interface between water- and lipid-based components on the out-of-phase image (arrows in d) relative to the signal intensity on the in-phase image (c), thus confirming the presence of a fat component. (e) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal suppression (arrowheads).
|
|
View larger version (175K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 12b. Mature cystic teratoma of the left ovary. (a) Sagittal transabdominal US image shows a large, heterogeneous, predominantly hyperechoic mass (arrows). (b) Axial contrast-enhanced CT image shows the retrouterine mass (arrows), which is predominantly of fat attenuation. (c, d) Axial in-phase (c) and out-of-phase (d) MR images show signal loss at the interface between water- and lipid-based components on the out-of-phase image (arrows in d) relative to the signal intensity on the in-phase image (c), thus confirming the presence of a fat component. (e) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal suppression (arrowheads).
|
|
View larger version (135K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 12c. Mature cystic teratoma of the left ovary. (a) Sagittal transabdominal US image shows a large, heterogeneous, predominantly hyperechoic mass (arrows). (b) Axial contrast-enhanced CT image shows the retrouterine mass (arrows), which is predominantly of fat attenuation. (c, d) Axial in-phase (c) and out-of-phase (d) MR images show signal loss at the interface between water- and lipid-based components on the out-of-phase image (arrows in d) relative to the signal intensity on the in-phase image (c), thus confirming the presence of a fat component. (e) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal suppression (arrowheads).
|
|
View larger version (153K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 12d. Mature cystic teratoma of the left ovary. (a) Sagittal transabdominal US image shows a large, heterogeneous, predominantly hyperechoic mass (arrows). (b) Axial contrast-enhanced CT image shows the retrouterine mass (arrows), which is predominantly of fat attenuation. (c, d) Axial in-phase (c) and out-of-phase (d) MR images show signal loss at the interface between water- and lipid-based components on the out-of-phase image (arrows in d) relative to the signal intensity on the in-phase image (c), thus confirming the presence of a fat component. (e) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal suppression (arrowheads).
|
|
View larger version (148K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 12e. Mature cystic teratoma of the left ovary. (a) Sagittal transabdominal US image shows a large, heterogeneous, predominantly hyperechoic mass (arrows). (b) Axial contrast-enhanced CT image shows the retrouterine mass (arrows), which is predominantly of fat attenuation. (c, d) Axial in-phase (c) and out-of-phase (d) MR images show signal loss at the interface between water- and lipid-based components on the out-of-phase image (arrows in d) relative to the signal intensity on the in-phase image (c), thus confirming the presence of a fat component. (e) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal suppression (arrowheads).
|
|
At MR imaging, the sebaceous component has high signal intensity on T1-weighted images, similar to that of retroperitoneal fat. The signal intensity on T2-weighted images is variable, usually approximating that of fat. Hemorrhagic lesions including endometriomas may have similar signal intensities on T1-weighted images but are usually darker than MCTs on T2-weighted images. Frequency-selective fat saturation or chemical shift artifact enables accurate differentiation of teratomas from hemorrhagic lesions (Figs 2, 12) (38,39). A minority of MCTs do not demonstrate a sebum-filled cyst cavity. However, they usually demonstrate evidence of fat in the wall or in the Rokitansky nodule (40).
Immature teratomas differ from MCTs in that they contain immature or embryonic tissues at histologic analysis, demonstrate clinically malignant behavior, are much less common (<1% of teratomas), and affect a younger group (during the first 2 decades of life). Mature cystic elements similar to those seen in MCTs are invariably present. However, solid components usually dominate over small foci of fat, and calcifications tend to be coarse or ill-defined. Recognition of these differential imaging and demographic features permits the correct diagnosis to be suggested.
Liposarcoma
Liposarcoma is a malignant tumor of mesenchymal origin that may arise in any fat-containing region of the body. Liposarcoma is one of the most common primary neoplasms in the retroperitoneum. It rarely arises in the mesentery or peritoneum (41). Histologically, liposarcomas are classified, in increasing order of malignancy, as well-differentiated, myxoid, pleomorphic, and round cell subtypes. Liposarcomas may contain multiple histologic subtypes within the same lesion. CT and MR imaging appearances vary according to these histologic subtypes (42).
Well-differentiated liposarcomas resemble lipomas, with attenuation (CT) and signal intensity (MR imaging) equal to those of fat. Fibrous septa may be thicker, more irregular, or more nodular than those seen in lipoma. These septa have attenuation (CT) and signal intensity (MR imaging) similar to those of muscle and may enhance dramatically on fat-suppressed T1-weighted MR images after administration of a gadolinium chelate (Figs 13, 14) (42–44). These tumors often recur if only marginally excised but do not metastasize.
View larger version (170K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 13. Mesenteric liposarcoma. Axial contrast-enhanced CT image shows a well-defined, slightly heterogeneous mass with fatty components in the mesentery. The mass causes posterior displacement of some abdominal structures (arrowhead) and anterior displacement of the small intestine (arrows). The thin, fibrous internal septa of soft tissue attenuation suggest the diagnosis of liposarcoma. An identical mass arising from the adrenal gland or kidney would be considered benign.
|
|
View larger version (167K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 14a. Retroperitoneal liposarcoma. (a) Transabdominal US image shows a large, well-defined, hyperechoic mass (cursors) in the abdominal cavity. The mass demonstrates the attenuation of sound, which is indicative of fat. (b) Axial contrast-enhanced CT image shows heterogeneous fat attenuation and coarse, thickened septa in the mass (arrows), findings suggestive of a well-differentiated liposarcoma. (c, d) Axial in-phase (c) and out-of-phase (d) gradient-echo MR images show signal loss in the interface between lipid and water on the out-of-phase image (arrowheads in d) relative to the signal intensity on the in-phase image (c), a finding that confirms the presence of a fatty component. (e) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal loss of the macroscopic fatty components (arrows), a finding that confirms the predominantly fatty content of the mass.
|
|
View larger version (184K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 14b. Retroperitoneal liposarcoma. (a) Transabdominal US image shows a large, well-defined, hyperechoic mass (cursors) in the abdominal cavity. The mass demonstrates the attenuation of sound, which is indicative of fat. (b) Axial contrast-enhanced CT image shows heterogeneous fat attenuation and coarse, thickened septa in the mass (arrows), findings suggestive of a well-differentiated liposarcoma. (c, d) Axial in-phase (c) and out-of-phase (d) gradient-echo MR images show signal loss in the interface between lipid and water on the out-of-phase image (arrowheads in d) relative to the signal intensity on the in-phase image (c), a finding that confirms the presence of a fatty component. (e) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal loss of the macroscopic fatty components (arrows), a finding that confirms the predominantly fatty content of the mass.
|
|
View larger version (138K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 14c. Retroperitoneal liposarcoma. (a) Transabdominal US image shows a large, well-defined, hyperechoic mass (cursors) in the abdominal cavity. The mass demonstrates the attenuation of sound, which is indicative of fat. (b) Axial contrast-enhanced CT image shows heterogeneous fat attenuation and coarse, thickened septa in the mass (arrows), findings suggestive of a well-differentiated liposarcoma. (c, d) Axial in-phase (c) and out-of-phase (d) gradient-echo MR images show signal loss in the interface between lipid and water on the out-of-phase image (arrowheads in d) relative to the signal intensity on the in-phase image (c), a finding that confirms the presence of a fatty component. (e) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal loss of the macroscopic fatty components (arrows), a finding that confirms the predominantly fatty content of the mass.
|
|
View larger version (162K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 14d. Retroperitoneal liposarcoma. (a) Transabdominal US image shows a large, well-defined, hyperechoic mass (cursors) in the abdominal cavity. The mass demonstrates the attenuation of sound, which is indicative of fat. (b) Axial contrast-enhanced CT image shows heterogeneous fat attenuation and coarse, thickened septa in the mass (arrows), findings suggestive of a well-differentiated liposarcoma. (c, d) Axial in-phase (c) and out-of-phase (d) gradient-echo MR images show signal loss in the interface between lipid and water on the out-of-phase image (arrowheads in d) relative to the signal intensity on the in-phase image (c), a finding that confirms the presence of a fatty component. (e) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal loss of the macroscopic fatty components (arrows), a finding that confirms the predominantly fatty content of the mass.
|
|
View larger version (151K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 14e. Retroperitoneal liposarcoma. (a) Transabdominal US image shows a large, well-defined, hyperechoic mass (cursors) in the abdominal cavity. The mass demonstrates the attenuation of sound, which is indicative of fat. (b) Axial contrast-enhanced CT image shows heterogeneous fat attenuation and coarse, thickened septa in the mass (arrows), findings suggestive of a well-differentiated liposarcoma. (c, d) Axial in-phase (c) and out-of-phase (d) gradient-echo MR images show signal loss in the interface between lipid and water on the out-of-phase image (arrowheads in d) relative to the signal intensity on the in-phase image (c), a finding that confirms the presence of a fatty component. (e) Axial gadolinium-enhanced fat saturation T1-weighted MR image shows marked signal loss of the macroscopic fatty components (arrows), a finding that confirms the predominantly fatty content of the mass.
|
|
Myxoid liposarcoma is the most common subtype, accounting for 50% of all liposarcomas. At CT, they often have an inhomogeneous appearance, with CT attenuation values less than that of muscle (Figs 15, 16). Occasionally, fat and soft tissue elements are distributed homogeneously within the lesion, producing fluid attenuation at CT. Consequently, the lesion may appear cystic on nonenhanced CT images and cause diagnostic confusion.
View larger version (157K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 15. Myxoid liposarcoma. Axial contrast-enhanced CT image shows a minimally heterogeneous mass with a mean CT number of 10 HU (arrows). Prospectively, the mass was erroneously diagnosed as a benign cyst on the basis of the fluid attenuation value. The correct diagnosis was made at surgery when the surgeon unexpectedly encountered an incompletely resectable solid mass. In retrospect, although the mean attenuation value within the lesion was 10 HU, the range of attenuation values on a pixel-by-pixel basis was –100 HU to 60 HU. Recognition of the broad range of attenuation values and the somewhat irregular septa within the mass may have permitted correct diagnosis with CT.
|
|
View larger version (180K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 16a. Myxoid liposarcoma. Axial contrast-enhanced CT images show a lobulated inhomogeneous mass localized to the retroperitoneal space, with posterior displacement of the psoas muscle and anterior displacement of the retroperitoneal vessels. Portions of the mass have fluid attenuation owing to admixture of fatty and soft tissue components, similar to the lesion in Figure 15. Recognition of enhancing septa and mural components, which are more conspicuous on the delayed image (arrows in b), permitted the correct diagnosis.
|
|
View larger version (185K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 16b. Myxoid liposarcoma. Axial contrast-enhanced CT images show a lobulated inhomogeneous mass localized to the retroperitoneal space, with posterior displacement of the psoas muscle and anterior displacement of the retroperitoneal vessels. Portions of the mass have fluid attenuation owing to admixture of fatty and soft tissue components, similar to the lesion in Figure 15. Recognition of enhancing septa and mural components, which are more conspicuous on the delayed image (arrows in b), permitted the correct diagnosis.
|
|
At MR imaging, myxoid liposarcomas exhibit signal intensity similar to that of water: low signal intensity on nonenhanced T1-weighted images and high signal intensity on T2-weighted images. Thus, these malignant lesions may superficially resemble benign cysts at unenhanced MR imaging, but careful inspection usually reveals lacy, linear, or amorphous regions of high signal intensity on T1-weighted images and intermediate signal intensity on T2-weighted images. These represent intratumoral fat and permit the correct diagnosis (43). Recognition of chemical shift artifacts between water- and fat-based components also permits the correct diagnosis.
Although these lesions may superficially resemble cysts on unenhanced CT and MR images, they are readily differentiated after intravenous administration of contrast material. Slowly progressive, reticular enhancement is characteristic and reveals the solid nature of these tumors (43).
Pleomorphic and round cell liposarcomas are heterogeneous, nonfatty tumors. Therefore, it is usually impossible to differentiate them from other sarcomas.
|
Fat-containing Nonneoplastic Masses
|
|---|
Lipoma
Lipoma is a benign mesenchymal tumor that resembles normal fat. Fat within a lipoma cannot be distinguished histologically from normal fat; however, there are ultrastructural and biochemical differences. Most commonly, lipomas arise in soft tissues and skeletal muscle, but they may arise in any region of the body that contains fat, including the gastrointestinal tract. The colon is the most commonly affected bowel segment, accounting for 65%–75% of gastrointestinal lipomas, followed by the small bowel with about 20%–25% (45). Approximately 90%–95% of gastrointestinal lipomas arise in the submucosa. Most are asymptomatic and discovered incidentally. Complications of gastrointestinal lipomas include intussusception and intestinal bleeding.
Regardless of their location, lipomas have characteristic imaging features that permit reliable noninvasive diagnosis. Lipomas typically demonstrate homogeneous fatty attenuation at CT (Figs 17, 18) and homogeneous signal intensity identical to that of fat with all MR imaging pulse sequences (43). Thin fibrous septa of low signal intensity on T1- and T2-weighted images may traverse the lesion. Some lipomas have prominent fibrous septa and nodularity and may mimic well-differentiated liposarcomas at imaging.
View larger version (170K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 17. Lipoma of the pancreas. Axial contrast-enhanced CT image shows a large, homogeneous, fat attenuation mass within the pancreatic head (arrows), with lateral displacement of the common bile duct (arrowhead).
|
|
View larger version (154K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 18. Lipoma of the terminal ileum. Axial contrast-enhanced CT image shows a small, homogeneous, fat attenuation mass within the wall of the terminal ileum (arrow), an appearance that allows diagnosis of a lipoma.
|
|
Epiploic Appendagitis
Appendices epiploicae are pedunculated adipose structures protruding from the external surface of the colon into the peritoneal cavity. Appendices epiploicae typically measure 1–2 cm thick and 2–5 cm long and extend from the cecum to the rectosigmoid junction. Appendices epiploicae are prone to torsion leading to ischemic or hemorrhagic infarction, due to their limited blood supply, pedunculated shape, and excessive mobility. Infarction results in a focal inflammatory process called epiploic appendagitis (46,47). The condition usually manifests as localized abdominal pain in one of the lower quadrants and clinically mimics acute appendicitis or diverticulitis.
CT is usually diagnostic, avoiding unnecessary surgery. Characteristic findings include (a) a paracolonic oval fatty mass representing the infarcted or inflamed appendix epiploica, (b) a well-circumscribed hyperattenuating rim that surrounds the mass and represents the inflamed visceral peritoneal lining, and sometimes (c) a high-attenuation central dot representing engorged or thrombosed central vessels or central areas of hemorrhage (Fig 19) (48,49). Mild local reactive thickening of the adjacent colonic wall is often seen (48).
View larger version (175K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 19. Epiploic appendagitis. Axial contrast-enhanced CT image shows an ovoid mass of fat attenuation (open arrow) anterior to the descending colon. The mass is surrounded by a hyperattenuating rim. A central high-attenuation dot was seen on images obtained superiorly (not shown). Note also the moderate fat stranding (arrowhead) and the mild focal thickening of the adjacent colonic wall (solid arrow).
|
|
Omental Infarction
The greater omentum, composed of a double layer of peritoneum, appears on CT scans as a band of fatty tissue located just anterior to the transverse colon. Omental thickness is variable, depending primarily on visceral fat distribution. Numerous small omental vessels are typically visible. The pathophysiology of omental infarction is similar to that of epiploic appendagitis: torsion or spontaneous venous thrombosis. It usually occurs in the right lower or right upper quadrant, clinically mimicking appendicitis or cholecystitis (50). The right-sided predilection may be related to variant embryologic vascular development, which predisposes to right-sided venous thrombosis (51).
CT demonstrates a large, cake-like mass centered in the omentum (52) (Fig 20). The inflammatory mass may or may not lie immediately adjacent to the colon, depending on the precise site of the infarcted omentum. Reactive colonic wall thickening may occur but is usually mild relative to the degree of omental abnormality.
View larger version (185K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 20. Omental infarction. Axial contrast-enhanced CT image shows an inhomogeneous, round, high-attenuation fatty mass in the greater omentum (arrows). The mass is anterior to and exerts mass effect on the ascending colon. Mild adjacent wall thickening is also evident (arrowhead).
|
|
Omental infarction and epiploic appendagitis may have a similar imaging appearance. Failure to differentiate the two entities is common but not clinically relevant because the treatment of both conditions is conservative.
Mesenteric Panniculitis
Mesenteric panniculitis is a rare idiopathic disorder characterized by chronic nonspecific inflammation involving the adipose tissue of the bowel mesentery (53). It may be a paraneoplastic condition in some patients, although the association with the underlying malignancy is poorly understood.
The CT appearance includes a solitary well-defined mass of inhomogeneous fatty tissue at the root of the jejunal mesentery (Fig 21). Typically, there is envelopment of the superior mesenteric vessels without vascular narrowing, displacement of adjacent bowel loops, and well-defined soft tissue nodules (lymph nodes) scattered throughout the mass. A distinctive, hypoattenuating fatty halo typically surrounding the nodules and vessels is suggestive of mesenteric panniculitis but is nonspecific, since it can be found in other entities such as lymphoma. A hyperattenuating stripe partially surrounding the mass is also suggestive. The characteristic location, appearance, and asymptomatic or chronic presentation suggest the diagnosis.
View larger version (193K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 21. Mesenteric panniculitis. Axial contrast-enhanced CT image shows a well-defined, inhomogeneous fatty mass (arrowheads) with a hyperattenuating peripheral rim (open arrow). Note the fatty halos surrounding the mesenteric vessels and lymph nodes (solid arrows).
|
|
|
Other Abdominopelvic Fatty Masses
|
|---|
Diffuse lipomatous infiltration of the ileocecal valve is a cause of ileocecal valve enlargement. Cross-sectional imaging allows ready diagnosis of this entity when it is suspected after barium examination, obviating invasive colonoscopy.
Intussusception typically contains some mesenteric fat attached to the involved segments of the bowel (Fig 22). Approximately 90% of intussusceptions occur in children, and 10%–50% of cases in adults are idiopathic. Identifiable causes include tumors, Meckel diverticula, and previous surgery.
View larger version (144K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 22a. Intussusception in a patient with an ileal lipoma. (a) Axial CT image shows a small amount of mesenteric fat between the walls of the intussusceptum and the intussuscipiens (arrows). (b) Axial CT image obtained superiorly to a shows a leading lipoma (arrowhead).
|
|
View larger version (151K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 22b. Intussusception in a patient with an ileal lipoma. (a) Axial CT image shows a small amount of mesenteric fat between the walls of the intussusceptum and the intussuscipiens (arrows). (b) Axial CT image obtained superiorly to a shows a leading lipoma (arrowhead).
|
|
After gastric fundoplication, iatrogenic incorporation of perigastric fat often allows CT and MR imaging recognition of fat in the resultant postoperative gastroesophageal junction "mass."
Fibrofatty mesenteric proliferation associated with inflammatory bowel disease typically causes separation of bowel loops at barium examination. Focal or regionally prominent mesenteric fat (creeping fat) adjacent to bowel with a thickened wall is seen on CT (Figs 23–25) and MR images. Submucosal fat deposition is also a common finding at cross-sectional imaging in patients with inflammatory bowel disease (Figs 23–25). Recent evidence suggests that submucosal bowel wall fat may be a normal variant (54).
View larger version (137K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 23. Diffuse submucosal fat in the terminal ileum in an elderly patient with long-standing Crohn disease. Axial contrast-enhanced CT image shows fat attenuation within the submucosal layer of the terminal ileum (arrow). Approximately 30 cm of the distal ileum was involved (other images not shown). There is no mass effect.
|
|
View larger version (162K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 24. Fibrofatty mesenteric proliferation and submucosal fat deposition in an elderly patient with long-standing Crohn disease (same patient as in Fig 23). Axial contrast-enhanced CT image shows mild circumferential wall thickening with fat attenuation in the cecum and distal ileum (arrows) and fibrofatty mesenteric proliferation surrounding the affected bowel loops (arrowheads).
|
|
View larger version (142K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 25. Fatty proliferation and submucosal fat deposition in a patient with ulcerative colitis. Axial CT image shows fatty proliferation with fine stranding around the rectum (arrowheads). Note also the submucosal fat deposition (arrow).
|
|
Lipomatous infiltration of the pancreas, typically seen in patients with cystic fibrosis, can be easily diagnosed at cross-sectional imaging (Fig 26).
View larger version (125K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 26. Fatty replacement of the pancreas in a patient with cystic fibrosis. Axial contrast-enhanced CT image shows virtually complete replacement of pancreatic tissue by tissue with fat attenuation (arrowheads). Note the main pancreatic duct (arrow).
|
|
Diaphragmatic and abdominal wall hernias: Herniations of abdominal and pelvic fat may occur through diaphragmatic and abdominal wall musculature defects, as well as through anatomic vascular or neural canals (55). The more common diaphragmatic hernias include the anteromedial Morgagni hernia and the posterior Bochdalek hernia. Occasionally, esophageal hernias consist of only intraabdominal fat. The inguinal hernias are by far the most common canal hernias (Fig 27). Indirect hernias originate lateral to the inferior epigastric vessels, and direct hernias originate medially. Femoral hernias are more common in females. Less common hernias include spigelian (through the linea semilunaris), lumbar, and perineal.
View larger version (139K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 27. Inguinal hernia. Axial contrast-enhanced CT image shows a well-defined fatty mass within the inferior aspect of the right inguinal canal (arrow). The mass represents herniation of intraabdominal fat into the inguinal canal.
|
|
Pelvic lipomatosis is a nonmalignant overgrowth of homogeneous adipose tissue in the pelvis. Minimal fibrotic and inflammatory components may be interspersed. The fat overgrowth compresses soft tissue structures and may cause bladder outlet, ureteral, or vascular obstruction.
Pathologic processes engulfing normal fat: Normal fat can be surrounded and incorporated into a neoplastic or inflammatory lesion such as renal cell carcinoma, abscesses, urinoma, hematomas, and pancreatitis. The patient history and other imaging findings lead to the correct diagnosis.
|
Summary
|
|---|
Recognition of fat within an abdominal or pelvic lesion is important because it helps narrow the differential diagnosis. Although CT allows easy identification of macroscopic fat, it is not as reliable for lesions with microscopic fat. Several MR imaging techniques have been developed for fat suppression. Two of the most widely available are spectroscopic fat saturation and chemical shift (in-phase/opposed-phase) imaging. These MR imaging techniques are often powerful tools in the noninvasive evaluation of these lesions. Knowledge of clinical, anatomic, and imaging features is important in formulating an appropriate differential diagnosis and guiding patient care, often obviating invasive diagnostic procedures. The location of the fatty mass is crucial to the correct interpretation of the imaging findings. For example, a mass consisting of soft tissue and fatty components would be considered a benign myelolipoma if it arose from the adrenal gland (Fig 3), a benign angiomyolipoma if it arose from the kidney (Fig 9), an MCT if it arose from the ovary (Fig 2), and a malignant liposarcoma if it arose from the mesentery or retroperitoneum (Figs 13, 14).
|
Footnotes
|
|---|
Abbreviations: MCT = mature cystic teratoma,
STIR = short inversion time inversion-recovery
|
References
|
|---|
- Takahashi K, Honda M, Okubo RS, et al. CT pixel mapping in the diagnosis of small angiomyolipomas of the kidneys. J Comput Assist Tomogr 1993; 17:98-101.[Medline]
- Haider MA, Ghai S, Jhaveri K, Lockwood G. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology 2004; 231:711-716.[Abstract/Free Full Text]
- Hood MN, Ho VB, Smirniotopoulos JG, Szumowski J. Chemical shift: the artifact and clinical tool revisited. RadioGraphics 1999; 19:357-371.[Abstract/Free Full Text]
- Mao J, Yan H, Brey WW, Bidgood WD, Jr, Steinbach JJ, Mancuso A. Fat tissue and fat suppression. Magn Reson Imaging 1993; 11:385-393.[CrossRef][Medline]
- Delfaut EM, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotten A. Fat suppression in MR imaging: techniques and pitfalls. RadioGraphics 1999; 19:373-382.[Abstract/Free Full Text]
- Smith RC, Constable RT, Reinhold C, McCauley T, Lange RC, McCarthy S. Fast spin echo STIR imaging. J Comput Assist Tomogr 1994; 18:209-213.[Medline]
- Olsson CA, Krane RJ, Klugo RC, Selikowitz SM. Adrenal myelolipoma. Surgery 1973; 73:665-670.[Medline]
- Chen KT, Felix EL, Flam MS. Extra-adrenal myelolipoma. Am J Clin Pathol 1982; 78:386-389.[Medline]
- Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991; 179:415-418.[Abstract/Free Full Text]
- Commons RR, Callaway CP. Adenomas of the adrenal cortex. Arch Intern Med 1948; 81:37-41.[Abstract/Free Full Text]
- Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am J Roentgenol 1996; 166:531-536.[Abstract/Free Full Text]
- Peña CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 2000; 217:798-802.[Abstract/Free Full Text]
- McNicholas MM, Lee MJ, Mayo-Smith WW, Hahn PF, Boland GW, Mueller PR. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. AJR Am J Roentgenol 1995; 165:1453-1459.[Abstract/Free Full Text]
- Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992; 185:345-351.[Abstract/Free Full Text]
- Chung JJ, Semelka RC, Martin DR. Adrenal adenomas: characteristic postgadolinium capillary blush on dynamic MR imaging. J Magn Reson Imaging 2001; 13:242-248.[CrossRef][Medline]
- Dunnick NR. Adrenal imaging: current status. AJR Am J Roentgenol 1990; 154:927-936.[Free Full Text]
- Reinig JW. MR imaging differentiation of adrenal masses: has the time finally come? Radiology 1992; 185:339-340.[Free Full Text]
- Gentry LR, Gould HR, Alter AJ, Wegenke JD, Atwell DT. Hemorrhagic angiomyolipoma: demonstration by computed tomography. J Comput Assist Tomogr 1981; 5:861-865.[Medline]
- Belville JS, Morgentaler A, Loughlin KR, Tumeh SS. Spontaneous perinephric and subcapsular renal hemorrhage: evaluation with CT, US, and angiography. Radiology 1989; 172:733-738.[Abstract/Free Full Text]
- Ahmadi T, Itai Y, Takahashi M, et al. Angiomyolipoma of the liver: significance of CT and MR dynamic study. Abdom Imaging 1998; 23:520-526.[CrossRef][Medline]
- Hajdu SI, Foote FW, Jr. Angiomyolipoma of the kidney: report of 27 cases and review of the literature. J Urol 1969; 102:396-401.[Medline]
- Kim JK, Park SY, Shon JH, Cho KS. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology 2004; 230:677-684.[Abstract/Free Full Text]
- Sherman JL, Hartman DS, Friedman AC, Madewell JE, Davis CJ, Goldman SM. Angiomyolipoma: computed tomographic-pathologic correlation of 17 cases. AJR Am J Roentgenol 1981; 137:1221-1226.[Abstract/Free Full Text]
- Uhlenbrock D, Fischer C, Beyer HK. Angiomyolipoma of the kidney. Acta Radiol 1988; 29:523-524.[Medline]
- Wagner BJ, Wong-You-Cheong JJ, Davis CJ. Adult renal hamartomas. RadioGraphics 1997; 17:155-169.[Abstract]
- Israel GM, Bosniak MA, Slywotzky CM, Rosen RJ. CT differentiation of large exophytic renal angiomyolipomas and perirenal liposarcomas. AJR Am J Roentgenol 2002; 179:769-773.[Abstract/Free Full Text]
- Wills JS. Management of small renal neoplasms and angiomyolipoma: a growing problem. Radiology 1995; 197:583-586.[Free Full Text]
- Jinzaki M, Tanimoto A, Narimatsu Y, et al. Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology 1997; 205:497-502.[Abstract/Free Full Text]
- Bosniak MA, Megibow AJ, Hulnick DH, Horii S, Raghavendra BN. CT diagnosis of renal angiomyolipoma: the importance of detecting small amounts of fat. AJR Am J Roentgenol 1988; 151:497-501.[Abstract/Free Full Text]
- Hélénon O, Merran S, Paraf F, et al. Unusual fat-containing tumors of the kidney: a diagnostic dilemma. RadioGraphics 1997; 17:129-144.[Abstract]
- Zebedin D, Kammerhuber F, Uggowitzer MM, Szolar DH. Criteria for ultrasound differentiation of small angiomyolipomas (< or = 3 cm) and renal cell carcinomas. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1998; 169:627-632. [German].[Medline]
- Siegel CL, Middleton WD, Teefey SA, McClennan BL. Angiomyolipoma and renal cell carcinoma: US differentiation. Radiology 1996; 198:789-793.[Abstract/Free Full Text]
- Caruso PA, Marsh MR, Minkowitz S, Karten G. An intense clinicopathologic study of 305 teratomas of the ovary. Cancer 1971; 27:343-348.[CrossRef][Medline]
- Kido A, Togashi K, Konishi I, et al. Dermoid cysts of the ovary with malignant transformation: MR appearance. AJR Am J Roentgenol 1999; 172:445-449.[Abstract/Free Full Text]
- Outwater EK, Siegelman ES, Hunt JL. Ovarian teratomas: tumor types and imaging characteristics. RadioGraphics 2001; 21:475-490.[Abstract/Free Full Text]
- Caspi B, Appelman Z, Rabinerson D, et al. The growth pattern of ovarian dermoid cysts: a prospective study in premenopausal and postmenopausal women. Fertil Steril 1997; 68:501-505.[CrossRef][Medline]
- Buy JN, Ghossain MA, Moss AA, et al. Cystic teratoma of the ovary: CT detection. Radiology 1989; 171:697-701.[Abstract/Free Full Text]
- Yamashita Y, Torashima M, Hatanaka Y, et al. Value of phase-shift gradient-echo MR imaging in the differentiation of pelvic lesions with high signal intensity at T1-weighted imaging. Radiology 1994; 191:759-764.[Abstract/Free Full Text]
- Stevens SK, Hricak H, Campos Z. Teratoma versus cystic hemorrhagic adnexal lesions: differentiation with proton-selective fat-saturation MR imaging. Radiology 1993; 186:481-488.[Abstract/Free Full Text]
- Yamashita Y, Hatanaka Y, Torashima M, et al. Mature cystic teratomas of the ovary without fat in the cystic cavity: MR features in 12 cases. AJR Am J Roentgenol 1994; 163:613-616.[Abstract/Free Full Text]
- Enterline HT, Culberson JD, Rochlin DB, et al. Liposarcoma: a clinical and pathological study of 53 cases. Cancer 1960; 13:932-950.[CrossRef][Medline]
- Jelinek JS, Kransdorf MJ, Shmookler BM, Aboulafia AJ, Malawer MM. Liposarcoma of the extremities: MR and CT findings in the histologic subtypes. Radiology 1993; 186:455-459.[Abstract/Free Full Text]
- Munk PL, Lee MJ, Janzen DL, et al. Lipoma and liposarcoma: evaluation using CT and MR imaging. AJR Am J Roentgenol 1997; 169:589-594.[Free Full Text]
- Dooms GC, Hricak H, Sollitto R, et al. Lipomatous tumors and tumors with fatty component: MR imaging potential and comparison of MR and CT results. Radiology 1985; 157:479-483.[Abstract/Free Full Text]
- Agha FP, Dent TL, Fiddian-Green RG, et al. Bleeding lipomas of the upper gastrointestinal tract: a diagnostic challenge. Am Surg 1985; 51:279-285.[Medline]
- Ghahremani GG, White EM, Hoff FL, Gore RM, Miller JW, Christ ML. Appendices epiploicae of the colon: radiologic and pathologic features. RadioGraphics 1992; 12:59-77.[Abstract]
- Legome EL, Sims C, Rao PM. Epiploic appendagitis: adding to the differential of acute abdominal pain. J Emerg Med 1999; 17:823-826.[CrossRef][Medline]
- Rao PM, Wittenberg J, Lawrason JN. Primary epiploic appendagitis: evolutionary changes in CT appearance. Radiology 1997; 204:713-717.[Abstract/Free Full Text]
- Torres GM, Abbitt PL, Weeks M. CT manifestations of infarcted epiploic appendages of the colon. Abdom Imaging 1994; 19:449-450.[CrossRef][Medline]
- Sompayrac SW, Mindelzun RE, Silverman PM, Sze R. The greater omentum. AJR Am J Roentgenol 1997; 168:683-687.[Abstract/Free Full Text]
- Epstein LI, Lempke RE. Primary idiopathic segmental infarction of the greater omentum: case report and collective review of the literature. Ann Surg 1968; 167:437-443.[Medline]
- Van Breda Vriesman AC, Lohle PN, Coerkamp EG, Puylaert JB. Infarction of omentum and epiploic appendage: diagnosis, epidemiology and natural history. Eur Radiol 1999; 9:1886-1892.[CrossRef][Medline]
- Daskalogiannaki M, Voloudaki A, Prassopoulos P, et al. CT evaluation of mesenteric panniculitis: prevalence and associated diseases. AJR Am J Roentgenol 2000; 174:427-431.[Abstract/Free Full Text]
- Harisinghani MG, Wittenberg J, Lee W, Chen S, Gutierrez AL, Mueller PR. Bowel wall fat halo sign in patients without intestinal disease. AJR Am J Roentgenol 2003; 181:781-784.[Abstract/Free Full Text]
- Wechsler RJ, Kurtz AB, Needleman L, et al. Cross-sectional imaging of abdominal wall hernias. AJR Am J Roentgenol 1989; 153:517-521.[Free Full Text]
This article has been cited by other articles:
|
|
|
|
 
J. Schittenhelm, S. N Jacob, J. Rutczynska, I. Tsiflikas, R. Meyermann, and R. Beschorner
Extra-adrenal paravertebral myelolipoma mimicking a thoracic schwannoma
BMJ Case Reports,
March 5, 2009;
2009(mar02_1):
bcr0720080561 - bcr0720080561.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
F. H. Cassidy, T. Yokoo, L. Aganovic, R. F. Hanna, M. Bydder, M. S. Middleton, G. Hamilton, A. D. Chavez, J. B. Schwimmer, and C. B. Sirlin
Fatty Liver Disease: MR Imaging Techniques for the Detection and Quantification of Liver Steatosis
RadioGraphics,
January 1, 2009;
29(1):
231 - 260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. A. Catalano, A. E. Samir, D. V. Sahani, and P. F. Hahn
Pixel Distribution Analysis: Can It be Used to Distinguish Clear Cell Carcinomas from Angiomyolipomas with Minimal Fat?
Radiology,
June 1, 2008;
247(3):
738 - 746.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-C. Chang and K.-L. Liu
Colonic Lipoma With Intussusception
Mayo Clin. Proc.,
January 1, 2007;
82(1):
10 - 10.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Schaffler, U. Muller-Ladner, J. Scholmerich, and C. Buchler
Role of Adipose Tissue as an Inflammatory Organ in Human Diseases
Endocr. Rev.,
August 1, 2006;
27(5):
449 - 467.
[Abstract]
[Full Text]
[PDF]
|
|
|
Top
Abstract
LEARNING OBJECTIVES
